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Abstract
Objectives: l-dopa decarboxylase (DDC) is responsible for the synthesis of dopamine. 
Dopamine, which binds to the D2-dopamine receptor (D2R), plays an important role 
in the maintenance of pregnancy. Aim of our study was the analysis of DDC and D2R 
expression in placentas of spontaneous miscarriages (SMs) and recurrent miscarriages 
(RMs) in comparison to healthy controls.
Methods: Patients with SM (n = 15) and RM (n = 15) were compared with patients from 
healthy pregnancies (n = 15) (pregnancy weeks 7–13 each). Placental tissue has been 
collected from SMs and RMs from the first trimester (Department of Gynaecology and 
Obstetrics, LMU Munich) and from abruptions (private practice, Munich). Placental cell 
lines, BeWo- and JEG-3 cells, were stimulated with the trace amines T0AM and T1AM in 
vitro.
Results: Levels of DDC and D2R in trophoblasts and the decidua were lower in RMs 
in comparison to healthy controls. Stimulation of BeWo cells with T1AM significantly 
reduced DDC mRNA and protein levels. Via double-immunofluorescence, a DDC-positive 
cell type beneath decidual stromal cells and foetal EVT in the decidua could be detected.
Conclusions: Downregulation of DDC and D2R in trophoblasts of RMs reflects a reduced 
signal cascade of catecholamines on the foetal side.
Introduction
The D2-dopamine receptor (D2R) is expressed by the human 
placenta, and its expression increases with the gestational 
week, and it reaches a maximum at term (1). Dopamine 
plays a significant role in human placental endocrine 
function, and it has the ability to inhibit human placental 
lactogen (hPL) and human chorionic gonadotrophin 
production (2). Changes in placental D2R expression have 
been observed in pregnant patients with preeclampsia 
and hydatidiform moles, which consequently leads to 
modulations in signal transduction processes (1). D2R is 
a target receptor for various antipsychotic drugs, and it 
can interact with the trace amine-associated receptor 1 
(TAAR1), forming a functional heteromer (3, 4).
The enzyme l-dopa-decarboxylase (aromatic amino 
acid decarboxylase, DDC), which is expressed by the 
placenta, is responsible for the conversion of l-dopa into 
dopamine (5, 6). Additionally, DDC is involved in the 
synthesis of serotonin, tryptamine, phenylethylamine 
and histamine (12). DDC can be subjected to multiple 
regulatory mechanisms at various levels (7). 
Degradation of thyroid hormones results in the 
formation of trace amines (TAs), also referred to as 
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endogenous amines or thyronamines (3). TAs (3-T1AM, 
T0AM) are converted from l-thyroxin also through a 
decarboxylation process (8). As TAs and catecholamines are 
both derived from decarboxylation of the original amino 
acid tyrosine, a connection exists between their synthesis 
and their structure. TAs affect dopamine signalling 
through TAAR1 and D2R heteromers (3). In a recent study, 
we found an increase of TAAR1 levels in placental tissue 
of patients with spontaneous miscarriages (SMs) and 
recurrent miscarriages (RMs). We linked those findings 
with a possible increase in thyroid hormone degradation 
through decarboxylation in placental tissue (27).
Thyroid hormones play an important role during 
trophoblast differentiation and the neurofoetal 
development (9). They bind to the thyroid hormone 
receptor (THR), which belongs to the nuclear receptor 
superfamily. Nuclear receptors play a role in various 
physiological processes, and they act via transcriptional 
cis-regulation of target genes (10). The choline 
acetyltransferase and DDC are target genes for thyroid 
hormones, and gene expression is regulated through 
those enzymes (11).
Thyroid disorders such as hypothyroidism and 
hyperthyroidism are associated with miscarriages and 
stillbirths (12). Untreated hypothyroidism can result in 
a twofold increase of miscarriages and stillbirth rates; 
hence, the maintenance of an euthyroid state is crucial 
for a healthy pregnancy (13). Downregulation of THR 
expression in miscarriages can possibly be a compensatory 
reaction towards an increased concentration of thyroid 
hormone metabolites. Placental expression of the isoforms 
THRα1, THRβ1 and THRα2 increases with gestational 
age (14). In a previous study, we could demonstrate 
that mRNA and protein expression of THRα1, THRα2, 
THRβ1 and THRβ2 is downregulated in SMs and RMs 
(15). Classical thyroid hormones act epigenetically, while 
decarboxylated thyroid hormones act in the opposite 
direction through rapid actions like rapid lowering of 
body temperature and heart rate (16).
Aim of our study was to analyse the expression of 
DDC and D2R in healthy pregnancies and SMs as well 
as RMs, and to further identify the mechanisms that 
are responsible for the regulation of thyroid hormones 
during miscarriages. Additionally, the influence of thyroid 
hormone metabolites on the expression of DDC in 
trophoblast model cells was assessed in order to identify 
ligands that may partly be responsible for the induction 
of miscarriages.
Materials and methods
Tissue samples
Samples were retrieved from SMs (15 cases) and RMs (15 
cases), which were obtained from the archives of the 
Gynaecology and Obstetrics Department of the Ludwig 
Maximilians University of Munich, Germany, and which 
were collected between 2011 and 2012. Samples from 
elective terminations of pregnancy (ETPs, 15 cases) were 
collected in a private practice in Munich in the same time 
period. All women included in the study had no medical or 
family history. Hypothyroidism as well as hyperthyroidism 
were excluded in all women. History taking was systematic, 
aiming to exclude – apart from common disorders – the 
possible implication of clotting disorders and autoimmune 
diseases, already known as aggravating factors for 
increased risk for miscarriages. In all samples, analysis of 
chromosomal abnormalities was performed (15). Tissue 
samples were obtained by dilatation and curettage without 
any prior pharmaceutical induction. In cases of miscarriages, 
curettage was performed within 24 h after diagnosis. The 
average gestational age for SM was 10.1 ± 1.5 weeks, for RM 
10 ± 1.5 weeks and for ETP 10.6 ± 2.1 weeks. The mean maternal 
age for SM was 37.3 ± 4.1 years, for RM 37.6 ± 6.2 years and 
for ETP 32 ± 8.2 years. Further demographic and clinical data 
are shown in Table 1.
Ethical approval and informed consent
All procedures involving human participants were in 
accordance with the Ethical Standards of the Institutional 
Table 1 Maternal data overview.
 
Characteristic (unit)
Elective termination 
of pregnancies (n = 15)
Spontaneous 
miscarriages (n = 15)
Recurrent 
miscarriages (n = 15)
P value  
(Kruskal–Wallis test)
Maternal age (years) 32.4 ± 8.2 (20–45) 37.3 ± 4.1 (31–44) 37.6 ± 6.2 (22–45) 0.105
Gestational age (weeks of pregnancy) 9.6 ± 2.1 (7–13) 9.1 ± 1.5 (7–12) 9.0 ± 1.5 (7–12) 0.786
Gravidity 3.9 ± 2.1 (1–7) 1.3 ± 0.5 (1–2) 3.6 ± 1.2 (2–5) 0.002
Parity 2.0 ± 1.3 (0–4) 0.2 ± 0.4 (0–1) 1.3 ± 1.1 (0–3) 0.009
Values are given as mean ± s.d.; the range is given in parentheses.
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and/or National Research Committee and with the 
Helsinki Declaration of 1964 and its later amendments 
or comparable ethical standards. The study was approved 
by the Local Ethics Committee of the Ludwig Maximilian 
University of Munich (reference number of approval: 337-
06). Written informed consent has been obtained from 
the patients after full explanation of the purpose and 
nature of all procedures used.
Immunohistochemistry
Immunohistochemistry was performed as described 
in our recent study by Stavrou et  al. (17). After tissue 
retrieval, tissue samples were fixed in 3.7% formalin 
and embedded in paraffin. Formalin-fixed paraffin-
embedded sections (3 µm) were deparaffinised in 
Roticlear (Carl Roth, Karlsruhe, Germany), rehydrated 
and blocked with 6% H2O2/methanol (for DDC) and 3% 
H2O2/methanol (for D2R) for endogenous peroxidase 
activity for 20 min. Rehydration of the slides was 
performed using an alcohol gradient up to distilled 
water. The slides were then placed in a pressure cooker 
containing sodium citrate (pH = 6.0). To prevent any non-
specific binding of the primary antibodies, a blocking 
solution was used (Polymer Kit; Zytomed Systems, 
Berlin, Germany). Tissue sections were then incubated 
with the primary antibodies for 16 h at 4°C as listed in 
Table 2. Reactivity was detected by using the ZytoChem 
Plus HRP Polymer System (mouse/rabbit) (Zytomed, 
catalogue-ID: POLHRP-100; Source BioScience, 
Nottingham, UK) in accordance to the manufacturer’s 
protocol, and staining and counterstaining was 
carried out with diaminobecidine (DAB), respectively, 
Hemalaun. Appropriate positive controls (appendix for 
D2R, colon for DDC) and negative controls (negative 
control serum added on the third trimester placenta) 
(Negative Control for Super Sensitive Rabbit Antibodies, 
Rabbit IgG; Biogenics, Fremont, CA, USA) were included 
in each experiment (Supplementary Fig.  1, see section 
on supplementary data given at the end of this article). 
Per slide, ten fields were examined with the semi-
quantitative immunoreactive score (IRS) (18) by two 
independent observers using a Leitz Diaplan microscope 
(Leitz, Wetzlar, Germany). The IRS is calculated by 
multiplying the intensity of cell staining (0: none; 1: 
weak; 2: moderate; 3: strong) with the percentage of 
positively stained cells (0: no staining; 1: <10% of the 
cells; 2: 11–50%; 3: 51–80%; 4: >81%). 
Cell lines and cell stimulation
Cell line experiments were performed as described by 
Stavrou et al. (17). The choriocarcinoma cell lines BeWo 
(ECACC, Salisbury, UK) and JEG-3 (ATCC) were used for 
the study, which are useful models of human trophoblasts. 
The cells were cultured in DMEM (3.7 g/L NaHCO3, 4.5 g/L 
d-glucose, 1.028 g/L stable glutamine and Na-Pyruvate; 
Biochrom, Berlin, Germany). Ten percent heat-inactivated 
fetal calf serum (FCS) was supplemented to the medium 
and the solution was incubated at an atmospheric CO2 
concentration of 5% and at 37°C.
BeWo and JEG-3 cells were separately grown on 
sterile 12-multiwell slides at a density of 500,000 cells/
mL DMEM with 10% foetal cow serum. After 4 h, medium 
was changed to pure DMEM. The cells were stimulated 
with 0.01 nM or 0.1 nM thyronamine (T0AM) (Sigma-
Aldrich, catalogue-ID: 80345), 3-iodothyronamine (T1AM) 
(Cayman Chemical) and RO5203548 (Glixx Laboratories, 
Hopkinton, MA, USA) for 2 h (PCR samples) and 48 h 
(immunocytochemistry and Western blot samples), 
respectively. Control cells were incubated sans stimulants.
Immunocytochemistry
After an incubation of 48 h, the Quadriperm slides were 
fixated in an ethanol/methanol solution for 15 min. 
Between each of the experimental steps, the slides were 
washed in PBS (Biochrom). Next, the primary antibodies 
anti-DDC (polyclonal Rabbit IgG; LSBio, Seattle, WA, USA) 
and anti-DRD2 (polyclonal Rabbit IgG; LSBio) were applied 
for 16 h at 4°C. Incubation with the secondary antibody 
Reagent II from the ZytoChem Plus HRP Polymer System 
(mouse/rabbit) (Zytomed: Nr. POLHRP-100) for 20 min at 
4°C and afterwards with Reagent III for 30 min at room 
temperature followed. Next, the slides were incubated 
with the ABC complex for 30 min. Staining of the slides 
Table 2 Features of the antibodies used for staining.
Antibody Incubation Blocking solution Blocking condition (min)
DDC, polyclonal (Rabbit IgG, LSBio) 1:300 in PBS, 16 h at 4°C Reagent I (Polymer Kit, Zytomed Systems) 5
DRD2, polyclonal (Rabbit IgG, LSBio) 1:100 in PBS, 16 h at 4°C Reagent I (Polymer Kit, Zytomed Systems) 5
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was carried out with 3-amino-9-ethylcarbazole plus (AEC 
plus; Dako) for 8 min, followed by counterstaining with 
Hemalaun for 30 s, washing in tap water and cover-
slipping of the slides.
Examination and evaluation of the slides were carried 
out with a Leitz Diaplan light microscope (Leitz) and a 
digital camera system (JVC, Yokohoma, Japan). Two 
independent observers examined the slides. 
For each slide, six visual fields were examined at 10× 
overall magnification. For each field, all cells were counted 
and assigned to three groups (negative, low and medium/
strong staining).
TaqMan-real-time PCR
TaqMan PCR was performed as described by Pestka et al. 
(19). RNA of stimulated and control JEG-3 and BeWo 
cells was isolated using the NucleoSpinRNAII (Macherey-
Nagel, Düren, Germany). Quantification and evaluation 
of RNA samples was performed with the NanoPhotometer 
(Implen, Munich, Germany).
Reverse transcription was carried out using the 
High-Capacity cDNA reverse transcription kit (Applied 
Biosystems) with a temperature protocol of 25°C for 
10 min, 37°C for 2 h, 85°C for 5 s and final cooling at 4°C. 
PCR was performed in 96-well reaction plates holding 
a volume of 20 µL. Each well contained 1 µL TaqMan Gene 
Expression Assay 20× (Applied Biosystems), 10 µL TaqMan 
Universal PCR Master Mix 2× (Applied Biosystems), 8 µL 
H2O (DEPC-treated DI water, Sigma) and 1 µL sample. 
For the PCR assay, the ABI PRISM 7500 Fast (Applied 
Biosystems) was used with thermal cycling conditions of 
20 s at 95°C followed by 40 cycles of amplification with 
3 s at 95°C and 30 s at 60°C. To quantify the expression, 
the 2−ΔΔCT method was used applying β-actin as the 
housekeeping gene. Each experiment was validated three 
times. 
Western blot
Stimulated cell samples were lysed for 30 min with 
200 µL buffer solution consisting of a 1:100 dilution 
of protease inhibitor (Sigma-Aldrich) in RIPA buffer 
(Radioimmunoprecipitation assay buffer, Sigma-
Aldrich). The lysate was centrifuged, and a Bradford 
protein assay of the supernatant was performed. The 
proteins were separated according to their molecular 
weight using SDS-PAGE and transferred onto a PVDF 
membrane (Merck Millipore). Non-specific binding was 
blocked through a 1 h incubation of the membrane 
with Marvel-TBST for DDC staining and with 1× Casein 
Solution (Vector Laboratories, Burlingame, CA, USA) 
for β-Actin staining. The primary antibodies anti-DDC 
(polyclonal Rabbit IgG; LSBio) and Anti-β-Actin (Clone 
AC-15, Mouse IgG, Sigma), diluted in a 1:1000 in 
Marvel-TBST (TBS + Tween and milk powder) and 1:1000 
Casein solution, respectively, were applied for 16 h at 
4°C for β-actin and 1 h at room temperature for DDC. 
After rinsing with TBST, the membrane was incubated 
with biotinylated anti-rabbit IgG antibody and ABC-
AmP reagent (both Vectastain ABC-AmP Kit for rabbit 
IgG, Vector Laboratories) following the manufacturer’s 
protocol. Staining was performed using BCIP/NBT 
chromogenic substrate (Vectastain ABC-AmP Kit, Vector 
Laboratories). Detection was performed with Bio-Rad 
Universal Hood II (Bio-Rad Laboratories) and the findings 
were quantified using Bio-Rad Quantity One software 
(Bio-Rad Laboratories).
Double-immunofluorescence
To determine the cells that express D2R and DDC in 
the decidua, double-immunofluorescence analysis with 
markers for extravillous trophoblast (EVT) and decidual 
stroma cells was performed. Human leukocyte antigen 
G (HLAG), which is a marker for EVT, and prolactin, a 
marker for decidual stroma cells, were applied. Placental 
tissue of both ETP and RM groups were stained.
Double-immunofluorescence staining was carried 
out on placental slides of both ETP and RM groups. 
After retrieval, the tissue samples were fixed in 3.7% 
formalin and embedded in paraffin. Formalin-fixed 
paraffin-embedded sections (3 µm) were deparaffinised 
in Roticlear (Carl Roth), rehydrated and then blocked 
with 3% H2O2/methanol for endogenous peroxidase 
activity for 20 min. Rehydration of the slides was 
accomplished using an alcohol gradient up to 
distilled water. The slides were then put in a pressure 
cooker containing sodium citrate (pH = 6.0). Between 
each experimental step, the slides were washed in 
PBS (Biochrom) at room temperature and without 
light exposure. In order to block any non-specific 
binding of the primary antibodies, the sections were 
incubated with UltraVision Protein Block (Thermo 
Scientific, catalogue-ID.: TA060PBQ) for 15 min at room 
temperature. Then, the samples were incubated with 
1:100 Anti-DRD2 (polyclonal rabbit antibody; LSBio, 
catalogue-ID: LS-A1403), 1:300 anti-DDC (polyclonal 
rabbit antibody; LSBio, catalogue-ID: LS-B10123) and 
1:50 Anti-HLAG (monoclonal mouse IgG1, clone: 
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MEM-6/9; Biocompare, South San Francisco, CA, USA, 
catalogue-ID: MCA2043) antibodies diluted in Antibody 
Diluent (Dako, catalogue-ID: S3022) for 16 h at 4°C. 
Slides were then exposed to the secondary antibodies, 
Cy2-labelled goat-anti-mouse IgG (Dianova, Hamburg, 
Germany), diluted 1:100 in Dako Antibody Diluent and 
Cy3-labelled goat-anti-rabbit IgG (Dianova) diluted 
1:500 in Dako Antibody Diluent. Finally, the sections 
were embedded in Vectashield Antifade Mounting 
Medium with 4,6-diamino-2-phenylindole (Vector 
Laboratories, catalogue-ID: H-1200) and inspected with 
a fluorescent Axioskop photomicroscope (Zeiss). Images 
were acquired with a digital Axiocam camera system 
(Zeiss).
Statistics
Data collection and processing as well as analysis of 
statistical data were performed with IBM SPSS Statistics for 
Windows, version 22.0 (IBM Corp, Armonk, NY). P values 
smaller than 0.05 were considered statistically significant. 
Non-parametric Mann–Whitney U test was performed 
for comparison of means. Wilcoxon signed-rank test was 
performed for the statistical analysis of cell culture tests. 
As the causes for either SMs or RMs are different, those 
groups were not compared with each other. 
Results
DDC protein expression in the placenta
DDC protein expression in villous trophoblasts of RMs 
was significantly reduced in comparison to DDC protein 
expression in villous trophoblasts of normal pregnancies 
(P = 0.049) (Fig. 1; Table 3). In decidual cell populations, 
DDC protein expression was also significantly 
downregulated (P = 0.018) in RMs (Fig.  1; Table 3). 
Significant differences of DDC expression between SMs 
(P = 0.669) and healthy controls were found neither in first 
trimester placentas nor in the decidua (P = 0.252) (Fig. 1; 
Table 3). 
D2R protein expression in the placenta
In syncytiotrophoblasts and villous cytotrophoblasts of 
RMs, a significant downregulation of D2R staining could 
be shown in comparison to healthy controls (P = 0.007) 
(Fig. 2; Table 4). In the decidua and glands, no significant 
difference in D2R protein expression could be detected 
(decidua: P = 0.349; glands: P = 0.710). In SMs, D2R protein 
expression did not differ from uncomplicated pregnancies 
(syncytiotrophoblasts: P = 0.469; decidua: P = 0.756; 
glands: P = 0.386). 
DDC mRNA expression in BeWo trophoblast model 
cells after stimulation with T0AM and T1AM
Incubation of BeWo cells with 0.1 nM T0AM induced a 
significant downregulation of DDC mRNA expression 
(P = 0.020) (Fig.  3A; Table 5). At a lower concentration 
(0.01 nM), a downregulation of DDC mRNA could also 
be shown; however, the difference was not significant 
(P = 0.394) (Fig. 3A; Table 5). The stimulant T1AM induced 
a significant downregulation of DDC mRNA expression 
in BeWo cells at both concentrations (P = 0.002 for 
0.01 nM and P = 0.025 for 0.1 nM (Fig.  3A). In JEG-3 
cells, 0.01 nM T1AM induced a significant (P = 0.005) 
downregulation of DDC mRNA expression (Fig.  3C; 
Table 5). At a concentration of 0.1 nM, T1AM had no 
effect on the expression of DDC in JEG-3 cells (P = 0.065) 
(Fig. 3C; Table 5). 
DDC protein expression in BeWo trophoblast model 
cells after stimulation with T0AM and T1AM
Immunocytochemistry
The influence of T0AM and T1AM on DDC expression in 
BeWo and JEG-3 cells has also been studied on protein 
level. Obtained by immunocytochemistry, a significant 
(P = 0.025) downregulation of DDC expression in BeWo 
cells induced by 0.01 nM T0AM could be detected (Fig. 4; 
Table 6). At a concentration of 0.1 nM, T1AM did not lead 
to a significant difference in DDC protein expression 
in comparison to unstimulated BeWo cells (P = 0.058) 
(Fig.  4; Table 6). A similar trend could be observed for 
the endogene ligand T1AM, which induced a significant 
downregulation of DDC protein expression in BeWo 
cells for 0.01 nM (P < 0.001) and 0.1 nM (P = 0.002) (Fig. 4; 
Table 6). 
Western blot
The same trend as observed via immunocytochemistry 
could be detected for Western blotting where 0.01 nM 
(P = 0.048) and 0.1 nM (P = 0.007) of T0AM induced a 
significant downregulation of DDC protein expression in 
BeWo trophoblast model cells (Fig.  5A and C; Table 7). 
For T1AM, only the lower concentration level (0.01 nM) 
induced a significant downregulation of DDC protein 
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expression after 48 h (P = 0.007) in BeWo cells (Fig. 5B and 
C; Table 7). 
In JEG-3 cells, a different influence of T0AM 
and T1AM on DDC expression could be observed in 
comparison to BeWo cells. The stimulant T0AM led to 
a significant upregulation of DDC protein expression 
after an incubation time of 48 h and at a concentration 
of 0.1 nM (P = 0.048) (Fig.  5D and F; Table 7). The 
endogene ligand T1AM also induced a significantly 
increased expression of DDC in JEG-3 cells at a 
concentration of 0.1 nM (P = 0.038) (Fig. 5E and F; Table 
7). At a lower concentration, both stimulants had no 
significant influence on DDC expression in JEG-3 cells 
(Fig. 5D and E; Table 7). 
Coexpression of DDC and D2R in 
EVTs double-immunofluorescence
In ETP decidual tissue HLAG-positive cells are stained 
in green (Fig.  6B), and HLAG-negative cells both 
expressing D2R are stained in red (Fig.  6A). Triple filter 
excitation shows the non-exclusive double staining of 
D2R and HLAG in yellow. In RM decidua, less double-
immunofluorescence staining can be seen (Fig.  6F), 
showing that in placentas of RMs, the ETP expresses less 
D2R than in healthy pregnancies. 
DDC expression in ETP (Fig.  6G) and RM placentas 
(Fig.  6K), which is stained in red, occurred mostly in 
HLAG-negative cells. EVT, stained in green, (Fig. 6H and L) 
Figure 1
DDC protein expression in villous trophoblasts and decidual cells. (A) Boxplot of DDC protein expression in villous trophoblasts, (B) stronger DDC staining 
in villous trophoblasts of control tissue, ×25 magnification, (C) lower DDC staining in villous trophoblasts of SMs, ×25, (D) lower DDC staining of RMs, 
villous trophoblasts, ×25, (E) lower DDC staining of RMs, villous trophoblasts, ×10, (F) boxplot of DDC protein expression in decidual cells, (G) control 
decidua, ×10, (H) control decidua, ×25, (I) RM decidua, ×10, (J) RM decidua, ×25. DDC, l-dopa decarboxylase; RM, recurrent miscarriage; SM, spontaneous 
miscarriage.
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showed very little DDC expression, resulting in low 
double staining in triple filter excitation in both samples 
(Fig. 6I and M). 
In both ETP (Fig. 6N, O and P) and RM (Fig. 6Q, R 
and S) samples, decidual stroma cells, stained in green 
(Fig. 6O and R), showed a coexpression for DDC (Fig. 6P 
and S). Furthermore, prolactin-negative cells expressing 
DDC could be detected, suggesting a DDC-positive cell 
type beneath maternal decidual stromal cells and foetal 
EVT in the decidua.
Discussion
In this study, the regulation of DDC and D2R has 
been described in the placenta of healthy pregnancies 
and in SMs as well as RMs. The nature of our sample 
collection of legal termination of pregnancy cases of 
SMs and RMs does not allow large sample collections as 
for example shown in cancer studies. Therefore, studies 
of first trimester placental tissue are always of limited 
numbers. That is why type 2 errors may occur in general 
in these types of studies. A significant downregulation 
of DDC expression in trophoblasts and the decidua 
of RMs and a significantly reduced expression of 
D2R in syncytiotrophoblats and cytotrophoblasts of 
miscarriages in comparison to healthy pregnancies 
could be identified. As DDC is involved in the 
synthesis of dopamine, downregulation of DDC and 
D2R in trophoblasts of RMs reflects a reduced signal 
cascade of catecholamines on the foetal side. Further 
studies are necessary to answer the question, whether 
a negative feedback loop of biologic active amines 
leads to a downregulation of DDC in miscarriages. A 
compensational reduced synthesis of amines induced by 
the DDC could also be discussed in this situation. Less 
production of amines may further lead to a decrease in 
epinephrine synthesis and consequently a reduced D2R 
expression. Blohberger et al. detected DDC expression in 
theca cells of the ovary and assume a correlation between 
DDC expression and higher dopamine levels within the 
ovary (6). Generation of dopamine from L-DOPA is the 
standard treatment for Parkinson’s disease (20, 21, 22). 
DDC activity regulation plays an important role during 
the treatment of Parkinson’s disease, and fluctuation 
of DDC activity can cause severe side effects of chronic 
L-DOPA administration (23, 24). 
The aims of this study included the analysis of the 
influence of endogene amines on DDC expression in 
Table 3 Raw numbers to Fig. 1.
IRS mean IRS 25th percentile IRS 75th percentile
DDC expression in villous trophoblast
 ETP 12 8 12
 SM 8 6 12
 RM 8 8 8
DDC expression in decidual cells
 ETP 12 10 12
 SM 8 8 12
 RM 5 4 8
DDC, l-dopa decarboxylase; ETP, elective termination of pregnancy; IRS, 
immunoreactive score; RM, recurrent miscarriage; SM, spontaneous 
miscarriage.
Figure 2
D2R protein expression in syncytio- and cytotrophoblasts. Boxplot of D2R 
expression in syncytiotrophoblasts of control placental tissue and 
recurrent miscarriages. In syncytiotrophoblasts of control placental tissue 
(A, ×25) a significantly higher expression and distribution of D2R 
expression could be detected in comparison to the recurrent miscarriages 
(B, ×25). D2R, D2-dopamine receptor; IRS, immunoreactive score.
Table 4 Raw numbers to Fig. 2.
IRS mean IRS 25th percentile IRS 75th percentile
D2R expression in syncytiotrophoblasts
 ETP 12 12 12
 RM 10 8 12
D2R, D2-dopamine receptor; ETP, elective termination of pregnancy; IRS, 
immunoreactive score; RM, recurrent miscarriage.
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trophoblast model cells and to determine whether 
the ligands may be responsible for the induction of 
miscarriages. Enhanced transformation of thyroid 
hormones into biological active amines may partly 
be responsible for miscarriages. Miscarriages are 
accompanied by a downregulation of the classical THRs, 
which can be due to an alteration in the transformation 
of thyroid hormones into TAs (15). The latter are closely 
related to classical monoamines like dopamine, and they 
can function via TAAR1 (3). Harmeier et al. investigated 
TAAR1 and D2R heteromers in neuronal cells and pointed 
towards a crosstalk between TAAR1 and D2R (3). In our 
study, we were able to demonstrate that T3/T4 metabolites 
can downregulate DDC mRNA and protein expression in 
trophoblast model cells. Reduction of DDC expression 
induced by endogen amines, such as T0AM and T1AM, 
is possibly caused by a product inhibition through the 
transformation of thyroid hormones into T0AM und 
T1AM. A reduced level of thyroid hormones is described 
in disturbed pregnancies, which may consequently lead 
to a reduced expression of DDC and D2R in miscarriages. 
It also seems likely, that hypothyroidism or thyrotoxicosis 
leads to thyroid hormones dysregulation in placental 
tissue. Thus would also cause a dysregulation of thyroid 
hormone degradation products. These act not only on the 
DDC expression, but also on the heterodimer of D2R and 
TAAR1.
The influence of endogen amines on DDC has been 
analysed in BeWo- as well as JEG-3 trophoblast model 
cells, and in both cell lines, different DDC expression 
trends could be detected. BeWo cells are able to fuse, and 
they can form a syncytium and therefore rather resemble 
the characteristics of syncytiotrophoblasts (25). JEG-3 cells 
on the other hand resemble the characteristics of EVTs 
(26, 27). Due to the differing characteristics of BeWo and 
JEG-3 cells, different influences of the tested stimulants 
were detected on the expression patterns of DDC in both 
cell lines. 
Vassiliou et al. also focused on DDC in the placenta, 
and they purified and identified Annexin V as an 
Figure 3
Real-time TaqMan PCR in BeWo and JEG-3 cells after stimulation with T0AM and T1AM. (A) Bar chart of DDC mRNA expression in BeWo cells after 
incubation with T0AM detected via Real-time TaqMan-PCR. 0.1 nM T0AM induced a significant downregulation of DDC mRNA (P = 0.020). Downregulation 
of DDC mRNA after incubation with 0.01 nM T0AM was not significant (P = 0.394). b) Bar chart of DDC mRNA expression in BeWo cells after incubation 
with T1AM detected via Real-time TaqMan PCR. Both 0.001 nM and 0.1 nM T1AM induced a significant downregulation of DDC mRNA expression. (C) Bar 
chart of DDC mRNA expression in JEG-3 cells after incubation with T1AM detected via Real-time TaqMan PCR. DDC mRNA expression was significantly 
reduced (P = 0.005) in JEG-3 cells after incubation with 0.01 nM T1AM. For 0.1 nM T1AM, the difference was not significant. DDC, l-dopa decarboxylase.
Table 5 Raw numbers to Fig. 3.
T0AM T1AM
DDC mRNA expression in BeWo cells after incubation with
 Control 1 1
 0.01 nM 0.85 0.70
 0.1 nM 1.45 0.60
T1AM
DDC mRNA expression in JEG-3 cells after incubation with
 Control 1
 0.01 nM 0.7
 0.1 nM 0.8
DDC, l-dopa decarboxylase.
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endogenous inhibitor of DDC activity from the human 
placenta by mass spectrometry (5). The study group 
presumes that the existence of the endogen inhibitor 
of DDC may explain the lack of DDC activity in the 
decarboxylation of L-DOPA (5). In addition, very early 
studies showed that thyroid hormones can influence 
DDC in foetal tissue (28). Maternal hypothyroxinaemia 
can lead to impairment in the development of the 
foetal brain (28). The authors also found that this is 
accompanied by dysgenesis of certain neurotransmitter 
metabolic activities (choline acetyltransferase and DOPA 
decarboxylase) (28).
In conclusion, within this study, we could show 
an influence of thyroid hormone metabolites on the 
expression of DDC and D2R in healthy pregnancies 
and RMs. Therefore, thyroid hormone metabolites may 
influence the placental catecholamine receptor system. 
This study describes the status of DDC and D2R expression 
in decidual tissue. Since there is no activity assay for DDC 
in trophoblast cell lines, additional studies are needed to 
Figure 4
Immunocytochemistry of DDC protein expression in BeWo cells after stimulation with T0AM and T1AM. (A) Boxplot analysis of DDC expression 
showing a significant downregulation of DDC expression induced by 0.01 nM T0AM (P = 0.025). (B) DDC staining of control BeWo cells, (C) reduced 
DDC staining of BeWo cells treated with 0.01 nM T0AM, (D) slightly reduced but not significant staining of BeWo cells treated with 0.1 nM T0AM. 
(E) Boxplot analysis of DDC expression showing a significant downregulation of DDC expression induced by 0.01 nM and 0.1 nM T1AM. (F) DDC 
staining of control BeWo cells, (G) reduced DDC staining in BeWo cells after incubation with 0.01 nM and 0.1 nM T1AM (G). DDC, l-dopa 
decarboxylase (H).
Table 6 Raw numbers to Fig. 4.
Strongly stained cells mean (%) 25th percentile (%) 75th percentile (%)
DDC protein expression in BeWo cells after stimulation with T0AM
 Control 82 68 92
 0.01 nM 65 50 77
 0.1 nM 65 45 92
DDC protein expression in BeWo cells after stimulation with T1AM
 Control 75 61 98
 0.01 nM 50 43 75
 0.1 nM 60 50 66
DDC, l-dopa decarboxylase.
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investigate the functional correlations of DDC activity. 
Therefore, it can currently not be determined, whether 
our findings are of causative or associative nature. Future 
studies are necessary to analyse the effect of dopamine 
or epinephrine on DDC expression in the placenta and 
its influence on the pregnancy outcome. Furthermore, 
ligands that are able to upregulate DDC and D2R 
expression in trophoblasts should be identified.
Figure 5
Western blot analysis of DDC protein expression 
in BeWo and JEG-3 cells after stimulation with 
T0AM and T1AM. (A) Boxplot analysis of DDC 
expression in BeWo cells after incubation with 
T0AM, (B) boxplot analysis of DDC expression in 
BeWo cells after incubation with T1AM, (C) 
picture of Western blot membrane of BeWo cells 
where (a) standard protein ladder (Page Ruler 
Prestained Protein Ladder; Product# 26616; 
Thermo Scientific). (b, e) BeWo cell control group. 
(c) BeWo cells stimulated with 0.01 nM T0AM, (d) 
BeWo cells stimulated with 0.1 nM T0AM. (f) 
BeWo cells stimulated with 0.01 nM T1AM. (g) 
BeWo cells stimulated with 0.1nM T1AM. (D, A) 
Boxplot analysis of DDC expression in JEG-3 cells 
after incubation with T0AM, (E) boxplot analysis 
of DDC expression in JEG-3 cells after incubation 
with T1AM, (F) picture of Western blot membrane 
of JEG-3 cells where (a) Standard protein ladder 
(Page Ruler Prestained Protein Ladder; Product# 
26616; Thermo Scientific). (b, e) Jeg3 cell control 
group. (c) Jeg3 cells stimulated with 0.01 nM 
T0AM. (d) Jeg3 cells stimulated with 0.1 nM T0AM. 
(f) Jeg3 cells stimulated with 0.01 nM T1AM. (g) 
Jeg3 cells stimulated with 0.1 nM T1AM. DDC, 
l-dopa decarboxylase.
Table 7 Raw numbers to Fig. 5.
DDC/β-actin mean DDC/β-actin 25th percentile DDC/β-actin 75th percentile
Western blot of DDC expression in BeWo cells after incubation with T0AM
 Control 0.63 0.58 0.70
 0.01 nM 0.50 0.30 0.78
 0.1 nM 0.56 0.26 0.64
Western blot of DDC expression in BeWo cells after incubation with T1AM
 Control 0.47 0.27 0.57
 0.01 nM 0.42 0.24 0.43
 0.1 nM 0.28 0.26 0.56
DDC/β-actin mean 25th percentile 75th percentile
Western blot of DDC expression in JEG-3 cells after incubation with T0AM
 Control 0.19 0.12 0.63
 0.01 nM 0.24 0.14 0.89
 0.1 nM 0.21 0.04 0.51
Western blot of DDC expression in JEG-3 cells after incubation with T1AM
 Control 0.18 0.03 0.48
 0.01 nM 0.13 0.08 0.49
 0.1 nM 0.19 0.13 0.59
DDC, l-dopa decarboxylase.
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This is linked to the online version of the paper at https://doi.org/10.1530/
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Figure 6
Double-immunofluorescence (A–F) with anti-D2R 
(red) and anti-HLAG (green) antibodies. (A) D2R 
expression in decidua of ETP placenta stained in 
red. (B) HLAG expression in decidua of ETP 
placenta stained in green. (C) Double staining of 
both D2R and HLAG. A double expression is 
visible in yellow. (D) D2R expression in decidua of 
RM placenta stained in red. (E) HLAG expression 
in decidua of RM placenta stained in green. (F) 
Double staining of both D2R and HLAG. A double 
expression is visible in yellow. (G–M) Double-
immunofluorescence with anti-DDC (red) and 
anti-HLAG (green) antibodies. (G) DDC expression 
in decidua of ETP placenta stained in red. (H) 
HLAG expression in decidua of ETP placenta 
stained in green. (I) Double staining of both DDC 
and HLAG. A double expression is visible in 
yellow. (K) DDC expression in decidua of RM 
placenta stained in red. (L) HLAG expression in 
decidua of RM placenta stained in green. (M) 
Double staining of both DDC and HLAG. A double 
expression is visible in yellow. (N–S) Double-
immunofluorescence with anti-DDC (red) and 
anti-prolactin (green) antibodies. (N) DDC 
expression in decidua of ETP placenta stained in 
red. (O) Prolactin expression in decidua of ETP 
placenta stained in green. (P) Double staining of 
both DDC and prolactin. A double expression is 
visible in yellow. (Q) DDC expression in decidua of 
RM placenta stained in red. (R) Prolactin 
expression in decidua of RM placenta stained in 
green. (S) Double staining of both DDC and 
prolactin. A double expression is visible in yellow. 
DDC, l-dopa decarboxylase; D2R, D2-dopamine 
receptor; ETP, elective termination of pregnancy; 
RM, recurrent miscarriage.
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